Novartis India (BOM:500672) Accounts Payable & Accrued Expense : ₹691 Mil (As of Mar. 2024)

View and export this data going back to 1991. Start your Free Trial

What is Novartis India Accounts Payable & Accrued Expense?

Novartis India's quarterly accounts payable & accrued expense declined from Sep. 2023 (₹553 Mil) to Dec. 2023 (₹0 Mil) but then increased from Dec. 2023 (₹0 Mil) to Mar. 2024 (₹691 Mil).

Novartis India's annual accounts payable & accrued expense declined from Mar. 2022 (₹832 Mil) to Mar. 2023 (₹673 Mil) but then increased from Mar. 2023 (₹673 Mil) to Mar. 2024 (₹691 Mil).

Novartis India Accounts Payable & Accrued Expense Historical Data

The historical data trend for Novartis India's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis India Accounts Payable & Accrued Expense Chart

Novartis India Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

1,758.50

881.80

831.50

672.50

690.70

Novartis India Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															672.50	-	553.10	-	690.70

Novartis India Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Novartis India (BOM:500672) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis India Ltd (BOM:500672) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

Inspire BKC, Part of 601 & 701, Bandra Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051

Website

https://www.novartis.in

Novartis India Ltd is an Indian-based pharmaceutical company. The company is engaged in the trading of Drugs and Pharmaceuticals. It derives revenue from operations in India. The company single business segment namely Pharmaceuticals, Its Pharmaceutical business focuses on Bone and Pain, Calcium portfolio, Gynecology, and Neurosciences.

Novartis India (BOM:500672) Headlines

No Headlines